Hana Pharm Co Ltd (293480) - Total Liabilities

Latest as of June 2026: ₩114.94 Billion KRW ≈ $77.89 Million USD

Based on the latest financial reports, Hana Pharm Co Ltd (293480) has total liabilities worth ₩114.94 Billion KRW (≈ $77.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Hana Pharm Co Ltd to see how much of total assets are deployed in long-term investments.

Hana Pharm Co Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Hana Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 293480 asset base.

Hana Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hana Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Dharmaj Crop Guard Limited NSE:DHARMAJ	India	Rs5.12 Billion
NEOWIZ HOLDINGS Corporation KQ:042420	Korea	₩150.12 Billion
Devyser Diagnostics AB ST:DVYSR	Sweden	Skr112.20 Million
Polytec Holding AG VI:PYT	Austria	€256.24 Million
Canadian Net Real Estate Investment Trust V:NET-UN	Canada	CA$180.83 Million
Amotech Co. Ltd KQ:052710	Korea	₩175.85 Billion
CO2 Energy Transition Corp. Common Stock NASDAQ:NOEM	USA	$2.69 Million
Amica S.A. WAR:AMC	Poland	zł866.60 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Hana Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 293480 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hana Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hana Pharm Co Ltd (2016–2025)

The table below shows the annual total liabilities of Hana Pharm Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩104.73 Billion ≈ $70.98 Million	+43.79%
2024-12-31	₩72.83 Billion ≈ $49.36 Million	+3.46%
2023-12-31	₩70.40 Billion ≈ $47.71 Million	-9.24%
2022-12-31	₩77.57 Billion ≈ $52.57 Million	+50.34%
2021-12-31	₩51.60 Billion ≈ $34.97 Million	+16.74%
2020-12-31	₩44.20 Billion ≈ $29.95 Million	+3.50%
2019-12-31	₩42.70 Billion ≈ $28.94 Million	+15.43%
2018-12-31	₩36.99 Billion ≈ $25.07 Million	-38.60%
2017-12-31	₩60.25 Billion ≈ $40.83 Million	+1.94%
2016-12-31	₩59.11 Billion ≈ $40.06 Million	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$98.97 Million

₩146.04 Billion KRW

Market Cap Rank

#19321 Global

#956 in Korea

Share Price

₩8240.00

Change (1 day)

-0.96%

52-Week Range

₩8240.00 - ₩12290.00

All Time High

₩26028.86